Figure 2: The computed anti-proliferative dose-response curve of individual inhibitors against EGFR-ERK pathway mediated cell growth signaling.

(A) EGFR inhibitor; (B) BRaf inhibitor; (C) MEK inhibitor.

(A) EGFR inhibitor; (B) BRaf inhibitor; (C) MEK inhibitor.